Prosecution Insights
Last updated: April 19, 2026

Praxis Precision Medicines Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18546800 HEMI-CITRATE SALTS OF GABA-A POSITIVE ALLOSTERIC MODULATOR AND CRYSTALLINE FORM THEREOF CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Aug 17, 2023
18258418 KCNT1 INHIBITORS AND METHODS OF USE HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Jun 20, 2023
18004417 KCNT1 INHIBITORS AND METHODS OF USE HERNANDEZ, JACKSON J 1627 Final Rejection Jan 05, 2023
17975457 METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORS VALENROD, YEVGENY 1628 Non-Final OA Oct 27, 2022
17906893 KCNT1 INHIBITORS AND METHODS OF USE ROBINSON, MIKHAIL O'DONNEL 1627 Non-Final OA Sep 21, 2022

Managing Praxis Precision Medicines Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month